|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM363369325 |
| 003 |
DE-627 |
| 005 |
20240214232842.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202307051
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1292.xml
|
| 035 |
|
|
|a (DE-627)NLM363369325
|
| 035 |
|
|
|a (NLM)37844125
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Lou, Chengming
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Microfluidic Platforms for Real-Time In Situ Monitoring of Biomarkers for Cellular Processes
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 14.02.2024
|
| 500 |
|
|
|a Date Revised 14.02.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2023 Wiley-VCH GmbH.
|
| 520 |
|
|
|a Cellular processes are mechanisms carried out at the cellular level that are aimed at guaranteeing the stability of the organism they comprise. The investigation of cellular processes is key to understanding cell fate, understanding pathogenic mechanisms, and developing new therapeutic technologies. Microfluidic platforms are thought to be the most powerful tools among all methodologies for investigating cellular processes because they can integrate almost all types of the existing intracellular and extracellular biomarker-sensing methods and observation approaches for cell behavior, combined with precisely controlled cell culture, manipulation, stimulation, and analysis. Most importantly, microfluidic platforms can realize real-time in situ detection of secreted proteins, exosomes, and other biomarkers produced during cell physiological processes, thereby providing the possibility to draw the whole picture for a cellular process. Owing to their advantages of high throughput, low sample consumption, and precise cell control, microfluidic platforms with real-time in situ monitoring characteristics are widely being used in cell analysis, disease diagnosis, pharmaceutical research, and biological production. This review focuses on the basic concepts, recent progress, and application prospects of microfluidic platforms for real-time in situ monitoring of biomarkers in cellular processes
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a biomarkers
|
| 650 |
|
4 |
|a cellular process
|
| 650 |
|
4 |
|a in situ detection
|
| 650 |
|
4 |
|a microfluidic platform
|
| 650 |
|
7 |
|a Proteins
|2 NLM
|
| 650 |
|
7 |
|a Biomarkers
|2 NLM
|
| 700 |
1 |
|
|a Yang, Hongru
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Hou, Ying
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Huang, Haina
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Qiu, Jichuan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Chunhua
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Sang, Yuanhua
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Hong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Han, Lin
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 36(2024), 6 vom: 12. Feb., Seite e2307051
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:36
|g year:2024
|g number:6
|g day:12
|g month:02
|g pages:e2307051
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202307051
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 36
|j 2024
|e 6
|b 12
|c 02
|h e2307051
|